Tag: Novo Nordisk

Abbott and Novo Nordisk in Partnership

Abbott and Novo Nordisk today announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital health tools...

FDA Approved Haemophilia A of Novo Nordisk

Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application for ESPEROCT® for the treatment of adults and children with haemophilia A. ESPER...

Novo Nordisk Expects Fast-Track Review for New Semaglutide

Novo Nordisk has said it is accelerating launch preparations for its new diabetes pill semaglutide, after investing in a voucher that will allow a fast review of the drug in the US. The FDA grants ...

Drug Giants Should Explain High Prices on Insulin

Sanofi, Eli Lilly and Novo Nordisk have been sent letters by US lawmakers requesting information on the increased costs of insulin in recent years and the companies’ profit from sales of these product...

Novo Nordisk Expands to 11 Markets across Asia Pacific

novo nordisk
Danish pharma company and the Swiss market expansion expert have partnered to provide high-quality cGMP quaternary ammonium compounds in eleven markets across the region. DKSH’s Business Unit Perfo...

Dutch biotech signs drug development agreement with Novo Nordisk

Staten Biotechnology and Novo Nordisk have entered into a collaboration and exclusive option agreement to develop novel therapeutics for the treatment of hypertriglyceridaemia.

Novo Nordisk got the Beacon® Optofluidic platform

Berkeley Lights, Inc. and Novo Nordisk today announced that Novo Nordisk has purchased the Beacon® Optofluidic platform to accelerate workflows in cell line development and to use the platform for fut...

Novo Nordisk signed a Deal with e-Therapeutics to find Therapies for diabetes

e-Therapeutics will work with Novo for a year and use its technology to identify novel intervention strategies, biological pathways and compounds that could form the basis of new therapies. The UK ...

Novo Nordisk to invest $22 million in its US facility

Novo Nordisk
Novo Nordisk(Denmark), the world’s leading diabetes care company, will invest $22 million at its Clayton facility in Johnston County (North Carolina, USA). The move comes just ten months after Novo...

Novo Nordisk starts research collaboration with Embark Biotech

novo nordisk
Embark Biotech and Novo Nordisk entered into a research collaboration focusing on the discovery of novel treatments for obesity and its associated metabolic pathologies.

Novo Nordisk strikes a deal with Flex Digital Health

novo nordisk
Novo Nordisk has struck a deal with Flex Digital Health, part of the IoT logistics company Flex, formerly known as Flextronics.

Novo Nordisk sets up a GMP manufacturing facility in USA

novo nordisk
Novo Nordisk announced the establishment of a manufacturing site in Fremont, California (USA) to develop and produce stem cell-based therapies.

Novo Nordisk announced the global launch of connected insulin pens

Novo Nordisk announced plans to make the durable, connected insulin pens NovoPen® 6 and NovoPen Echo® Plus commercially available across key markets commencing in early 2019.

Novo Nordisk insulin full cycle production launched in Kaluga

novo-nordisk kaluga
An official ceremony dedicated to the launch of Novo Nordisk insulin full cycle production was held on September 19, 2018 in Grabtsevo Industrial Park, Kaluga Region.

Novo Nordisk intends to restructure its R&D organization

novo nordisk
Novo Nordisk announced plans to restructure its Research & Development (R&D) organisation to accelerate the expansion and diversification of its pipeline across serious chronic diseases.

Novo Nordisk opens a new research centre in Oxford

A new centre for research to develop a new generation of medicines that will transform the lives of people living with diabetes opened in Oxford (UK).